IDiyas

For the Inventor, By the Inventor

Ljubljana, Slovenia

Lek Pharmaceuticals D.d.


USPTO Granted Patents = 107



Forward Citations = 201

Loading Chart...
Loading Chart...

285 inventors (with patents filed for the assignee):

goldMedal Zdenko Casar (15 out of 15 patents)

silverMedal Anton Copar (10 out of 14 patents)

bronzeMedal Zlatko Pflaum (10 out of 11 patents)

4.  Rok Grahek (8 out of 9 patents)

5.  Janez Kerc (8 out of 9 patents)

6.  Igor Legen (7 out of 8 patents)

7.  Lovro Selic (6 out of 6 patents)

8.  Andrej Bastarda (6 out of 7 patents)

9.  Mateja Salobir (5 out of 5 patents)

10.  Damjan Sterk (5 out of 6 patents)

11.  Peter Mrak (5 out of 5 patents)

12.  Gregor Kopitar (5 out of 5 patents)

13.  Marko Zlicar (5 out of 5 patents)

14.  Viktor Menart (5 out of 5 patents)

15.  Renata Toplak Casar (5 out of 5 patents)


Core Competencies:
Recombinant Protein Production
Pharmaceutical Composition
Cell Culture Medium
Glycoproteins Production
Triazolopyrimidine Compounds
Mammalian Expression Vector
Sitagliptin Intermediates
Amorphous Calcium Salt
Coated Particles
Protein Expression
Statin Synthesis
Oxidative Degradation Products

107 patents:

1. 10913985 - Predicting productivity in early cell line development (2021-02-09),
2. 10913984 - Predicting genetically stable recombinant protein production in early cell line development (2021-02-09),
3. 10357431 - Process for the preparation of a pharmaceutical composition comprising a low soluble pharmaceutically active ingredient (2019-07-23),
4. 10335394 - Processes for preparing dolutegravir and cabotegravir and analogues thereof (2019-07-02),
5. 10323056 - Crystalline hydrates of 1-(β-D-glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl]benzene (2019-06-18),
6. 10196601 - Cell culture medium and process for controlling α-amidation and/or C-terminal amino acid cleavage of polypeptides (2019-02-05),
7. 9907757 - Coated particles and pharmaceutical dosage forms (2018-03-06),
8. 9732053 - 1-[2-(2,4-dimethylphenylsulfanyl) phenyl]piperazine acetate in crystalline form (2017-08-15),
9. 9707178 - Pharmaceutical composition (2017-07-18),
10. 9637769 - Reduction of formation of amidated amino acids in cell lines for protein expression (2017-05-02),
11. 9622976 - Pharmaceutical composition (2017-04-18),
12. 9562082 - Production of glycoproteins with low N-glycolylneuraminic acid (Neu5Gc) content (2017-02-07),
13. 9512097 - Process for the preparation of 3-aroyl-5-aminobenzofuran derivatives (2016-12-06),
14. 9499857 - Selection of triploid CHO cells and cell lines expressing recombinant polypeptides as high producers (2016-11-22),
15. 9493409 - Process for the synthesis of 1-(2-((2,4-dimethylphenyl)thio)phenyl)piperazine (2016-11-15),
Lek Pharmaceuticals d.d. is a pharmaceutical company based in Slovenia. We specialize in the development, production, and marketing of high-quality pharmaceutical products. With over 70 years of experience, we have become one of the leading companies in the pharmaceutical industry in Central and Eastern Europe. Our focus lies in the areas of generic and innovative drugs, biosimilars, and active pharmaceutical ingredients. We are committed to improving the health and well-being of people worldwide through our innovative and affordable healthcare solutions.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

107 Patents

#1 in Ljubljana

#1 in Slovenia

#7,106 in the World

...
Ljubljana, Slovenia

Lek Pharmaceuticals D.d.

Forward Citations = 201

285 inventors:

goldMedal Zdenko Casar (15 out of 15 patents)

silverMedal Anton Copar (10 out of 14 patents)

bronzeMedal Zlatko Pflaum (10 out of 11 patents)

4.  Rok Grahek (8 out of 9 patents)

5.  Janez Kerc (8 out of 9 patents)

Please report any incorrect information to support@idiyas.com
Loading…